ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.

Biotechnology

ADC Therapeutics

ADC Therapeutics' headquarters in Lausanne, Switzerland

Ameet Mallik

Christopher Keir

Robert Azelby

Karen Russo

Jim Jogerst

Jason Moss

Niall McConnell

Jesse Stromeyer

Jay Feingold

Jada Baijnath

Mohamed Zaki

Kristen Harrington-Smith

Jose Carmona

Kimberly Pope

Peter Graham

Patrick van Berkel

Bob Azelby

Ron Squarer

Stephen Evans-Freke

Viviane Monges

Peter Hug

Thomas Pfisterer

Tyrell J. Rivers

Victor Sandor

Jean-Pierre Bizzari

Description

People (2)

Zuzana B.

Chintu M

Jobs